PFIZER RECEIVES ZOLOFT OCD INDICATION WITHOUT DOSE-RESPONSE RELATIONSHIP; FIRM HAS SUBMITTED PROPOSED CORRECTIVE PLAN IN RESPONSE TO FDA WARNING LETTER